Incorporating Modern Competitive Intelligence Tactics for Pharmaceutical Companies
Digimind
NOVEMBER 4, 2019
The global pharmaceutical industry in itself is highly competitive, driven by a constant need to innovate and discover new drugs. With the average drug life cycle spanning two decades, from drug development to approval and commercialization, all the more multinational drug companies have unique challenges in competitive intelligence (CI).
Let's personalize your content